Robert Carter - Mar 19, 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Financial Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter
Stock symbol
TOI
Transactions as of
Mar 19, 2025
Transactions value $
-$1,022
Form type
4
Date filed
3/20/2025, 05:56 PM
Previous filing
Jan 7, 2025
Next filing
Mar 28, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Class A Common Stock Disposed to Issuer -$1.02K -1.15K -3.65% $0.89 30.4K Mar 19, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.